Cambridge Investment Research Advisors’s Embraer S.A. ADS EMBJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
5,536
-15,549
-74% -$954K ﹤0.01% 3066
2026
Q1
$1.25M Sell
21,085
-12,687
-38% -$869K ﹤0.01% 1972
2025
Q4
$2.17M Sell
33,772
-45
-0.1% -$2.82K 0.01% 1452
2025
Q3
$2.04M Buy
33,817
+2,541
+8% +$144K 0.01% 1494
2025
Q2
$1.78M Buy
31,276
+3,169
+11% +$150K 0.01% 1510
2025
Q1
$1.3M Sell
28,107
-1,880
-6% -$83.7K ﹤0.01% 1654
2024
Q4
$1.1M Buy
29,987
+13,575
+83% +$489K ﹤0.01% 1794
2024
Q3
$580K Sell
16,412
-260
-2% -$8.25K ﹤0.01% 2287
2024
Q2
$430K Buy
16,672
+8,791
+112% +$238K ﹤0.01% 2419
2024
Q1
$210K Buy
+7,881
New +$156K ﹤0.01% 2987
2023
Q2
Sell
-13,568
Closed -$222K 3206
2023
Q1
$222K Buy
+13,568
New +$181K ﹤0.01% 2742

Other funds holding EMBJ

Cambridge Investment Research Advisors's EMBJ Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Embraer S.A. ADS (EMBJ) stake by 74% in Q2 2026, selling an estimated $954K and leaving 5,536 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3066.

Cambridge Investment Research Advisors first reported a position in EMBJ in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.17M in Q4 2025. 84 funds tracked by Wall St. Rank hold EMBJ as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,536 shares of Embraer S.A. ADS worth $353K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 15,549 Embraer S.A. ADS shares in Q2 2026, an estimated $954K.
  • Embraer S.A. ADS made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3066 holding.
  • Cambridge Investment Research Advisors first reported a position in Embraer S.A. ADS in Q1 2023 and has held it in 11 quarters since.
  • Cambridge Investment Research Advisors's Embraer S.A. ADS position peaked at $2.17M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Embraer S.A. ADS as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.